TABLE 1A.

Comparison of clinical background in the test cohort (Kanazawa University)

		EphA2 < 50 pg/mL (n = 24)	EphA2 ≧ 50 pg/mL (n = 125)	P
PNET and IPMN (n = 52)	Age (year)	68a	72a	0.270b
	Gender (male/female)	8/13	19/12	0.100c
	CA19-9 (U/mL)	5.0a	6.0a	0.389b
PC (n = 97)	Age (year)	57a	67a	0.160b
	Gender (male/female)	0/3	66/28	0.010c
	CA19-9 (U/mL)	258.6a	440.0a	0.739b

Abbreviation: PC, pancreatic cancer.

^aMedian.

^b t test.

^c χ ² test.